Market Overview:
DXM and codeine syrup is a medication used to suppress a cough. It is available as an over-the-counter (OTC) and prescription drug. DXM and codeine syrup are also used to relieve pain, especially after surgery. The global DXM and codeine syrup market was valued at US$ XX Mn in 2017 and is projected to reach US$ XX Mn by 2030, exhibiting a CAGR of X%. The global DXM and codeine syrup market has been segmented on the basis of type, application, and region. On the basis of type, the market has been segmented into DXM-only syrups and promethazine-codeine cough syrups. Promethazine-codeine cough syrups are further subsegmented into single ingredient products (promethazine)and combination products (promethazine with codeine). On the basis of application, the market has been segmented into adult useand children’s use.
Product Definition:
DXM and Codeine Syrup are used as cough suppressants. They work by blocking the signals in the brain that cause coughing.
DXM:
The drug xanthan gum is used to treat stomach and intestinal disorders. It works by increasing the water content of the stomach and reducing constipation. The drug has gained popularity as a cough suppressant in recent years, but it was first developed as an anti-inflammatory agent for treating asthma.
It's main ingredient, xanthine oxidase inhibitor, is known as DXM (dextromethorphan/quinidine).
Promethazine-codeine Cough Syrup:
Promethazine-codeine cough syrup is a combination product that contains the active ingredient of codeine and Promethazine (a phenylephrine). It is available as a clear liquid in both 4oz and 32oz bottles with dosing cups. The product has found its use in treating upper respiratory ailments such as common cold, nasal congestion, allergies & asthma among others.
Application Insights:
The adult segment held the largest share of over 70.0% in 2017. The growing usage of DXM and cough syrups for the treatment of acute coughs and colds is expected to remain a prominent factor driving the demand for these products among adults. In addition, increasing awareness regarding codeine as an analgesic and anti-inflammatory agent is likely to propel market growth among adults during the forecast period.
The children application segment is expected to witness significant growth during the forecast period owing to rising prevalence rates of respiratory disorders such as asthma amongst this population group. According to data published by CDC, in 2015 approximately 6 million children under 5 years had doctor-diagnosed asthma while nearly 2 million were diagnosed with allergies/atopic disease which include asthma, nasal congestion, runny nose & eyes etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a rise in consumption of codeine cough syrup over the forecast period, owing to increasing sales of all brands, generics and brand-name products. DXM content in Promethazine-codeine syrup has been found to be effective against cough and cold viruses, which is one of the key reasons behind high demand for this product.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period due to rising consumer awareness regarding health issues coupled with increased spending on healthcare by consumers and manufacturers alike.
Growth Factors:
- Increasing awareness about the benefits of using DXM and Codeine Syrup for treating various medical conditions is expected to drive the market growth.
- Rising demand for over-the-counter drugs owing to their easy availability is another key factor that is anticipated to fuel the market growth in the near future.
- Growing number of research and development activities focused on developing novel therapeutics using DXM and Codeine Syrup is likely to create new opportunities for market players in the coming years.
- increasing prevalence of respiratory diseases, such as asthma, bronchitis, and pneumonia, is projected to boost demand for DXM and Codeine Syrup products over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
DXM and Codeine Syrup Market Research Report
By Type
DXM, Promethazine-codeine Cough Syrup
By Application
Adult, Children
By Companies
Pfizer, Atley Pharmaceuticals, Vertical Pharmaceuticals, Novartis, Merck, Johnson & Johnson, Toray Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global DXM and Codeine Syrup Market Report Segments:
The global DXM and Codeine Syrup market is segmented on the basis of:
Types
DXM, Promethazine-codeine Cough Syrup
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Atley Pharmaceuticals
- Vertical Pharmaceuticals
- Novartis
- Merck
- Johnson & Johnson
- Toray Industries
Highlights of The DXM and Codeine Syrup Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DXM
- Promethazine-codeine Cough Syrup
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DXM and Codeine Syrup Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DXM is a dissociative anesthetic that is found in over-the-counter cough and cold medicines. Codeine syrup is a pain reliever and opioid.
Some of the key players operating in the dxm and codeine syrup market are Pfizer, Atley Pharmaceuticals, Vertical Pharmaceuticals, Novartis, Merck, Johnson & Johnson, Toray Industries.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. DXM and Codeine Syrup Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DXM and Codeine Syrup Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DXM and Codeine Syrup Market - Supply Chain
4.5. Global DXM and Codeine Syrup Market Forecast
4.5.1. DXM and Codeine Syrup Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DXM and Codeine Syrup Market Size (000 Units) and Y-o-Y Growth
4.5.3. DXM and Codeine Syrup Market Absolute $ Opportunity
5. Global DXM and Codeine Syrup Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. DXM and Codeine Syrup Market Size and Volume Forecast by Type
5.3.1. DXM
5.3.2. Promethazine-codeine Cough Syrup
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global DXM and Codeine Syrup Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. DXM and Codeine Syrup Market Size and Volume Forecast by Application
6.3.1. Adult
6.3.2. Children
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global DXM and Codeine Syrup Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. DXM and Codeine Syrup Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global DXM and Codeine Syrup Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DXM and Codeine Syrup Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DXM and Codeine Syrup Demand Share Forecast, 2019-2026
9. North America DXM and Codeine Syrup Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DXM and Codeine Syrup Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DXM and Codeine Syrup Market Size and Volume Forecast by Application
9.4.1. Adult
9.4.2. Children
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America DXM and Codeine Syrup Market Size and Volume Forecast by Type
9.7.1. DXM
9.7.2. Promethazine-codeine Cough Syrup
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America DXM and Codeine Syrup Demand Share Forecast, 2019-2026
10. Latin America DXM and Codeine Syrup Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DXM and Codeine Syrup Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DXM and Codeine Syrup Market Size and Volume Forecast by Application
10.4.1. Adult
10.4.2. Children
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America DXM and Codeine Syrup Market Size and Volume Forecast by Type
10.7.1. DXM
10.7.2. Promethazine-codeine Cough Syrup
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America DXM and Codeine Syrup Demand Share Forecast, 2019-2026
11. Europe DXM and Codeine Syrup Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DXM and Codeine Syrup Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DXM and Codeine Syrup Market Size and Volume Forecast by Application
11.4.1. Adult
11.4.2. Children
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe DXM and Codeine Syrup Market Size and Volume Forecast by Type
11.7.1. DXM
11.7.2. Promethazine-codeine Cough Syrup
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Gowth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe DXM and Codeine Syrup Demand Share, 2019-2026
12. Asia Pacific DXM and Codeine Syrup Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DXM and Codeine Syrup Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DXM and Codeine Syrup Market Size and Volume Forecast by Application
12.4.1. Adult
12.4.2. Children
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific DXM and Codeine Syrup Market Size and Volume Forecast by Type
12.7.1. DXM
12.7.2. Promethazine-codeine Cough Syrup
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific DXM and Codeine Syrup Demand Share, 2019-2026
13. Middle East & Africa DXM and Codeine Syrup Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa DXM and Codeine Syrup Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DXM and Codeine Syrup Market Size and Volume Forecast by Application
13.4.1. Adult
13.4.2. Children
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa DXM and Codeine Syrup Market Size and Volume Forecast by Type
13.7.1. DXM
13.7.2. Promethazine-codeine Cough Syrup
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa DXM and Codeine Syrup Demand Share, 2019-2026
14. Competition Landscape
14.1. Global DXM and Codeine Syrup Market: Market Share Analysis
14.2. DXM and Codeine Syrup Distributors and Customers
14.3. DXM and Codeine Syrup Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Atley Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Vertical Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Toray Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
